Skip to main content
. 2020 Aug 5;120(10):2273–2287. doi: 10.1007/s00421-020-04450-1

Table 1.

Participant characteristics, including physiological parameters at baseline and follow-up

All participants (n = 25) CHO-P group (n = 13) CHO group (n = 12)
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Age (years) 20 ± 2 20 ± 2 20 ± 2
Speed at 70% V˙O2max (km h−1) 10.2 ± 1.0 10.7 ± 0.9 10.0 ± 1.0 10.6 ± 0.9 10.4 ± 0.9 10.9 ± 0.9
Speed at 75% V˙O2max (km h−1) 11.0 ± 1.0 11.6 ± 1.0 10.8 ± 1.1 11.4 ± 1.0 11.2 ± 1.0 11.8 ± 0.9
Height (cm) 179 ± 10 179 ± 10 179 ± 10
Body mass (kg) 76.3 ± 12 75.4 ± 10 77.7 ± 13 76.0 ± 11 73.9 ± 9 74.0 ± 8
Body fat (%) 16.3 ± 4.5 15.9 ± 3.6 15.8 ± 5.2 15.4 ± 3.9 17.0 ± 3.8 16.4 ± 3.4
Body mass index (kg m2) 23.8 ± 2.8 23.6 ± 2.3 24.3 ± 3.4 23.8 ± 2.7 23.1 ± 2.0 23.1 ± 1.7
Resting heart rate (beats min−1) 61 ± 7 56 ± 9* 63 ± 6 57 ± 8* 59 ± 7 54 ± 10*
Maximum heart rate (beats min−1) 203 ± 10 197 ± 9* 200 ± 12 195 ± 10* 206 ± 7 199 ± 7*
Resting metabolic rate (kJ min−1) 7721 ± 259 7733 ± 225 7686 ± 322 7849 ± 238 7757 ± 301 7607 ± 301
Urine osmolality (mOsm kg−1) 519 ± 347 592 ± 281 523 ± 349 584 ± 291 516 ± 359 600 ± 282

Values are mean ± SD

*Significant time effect from baseline to follow-up (p < 0.05)